42.5
Thérapie par Cellules Souches pour la Régénération des Tissus
La thérapie par cellules souches est une méthode utilisée en médecine régénérative pour réparer et restaurer la fonction des tissus et des organes end…
Les cellules souches sont des cellules non spécialisées qui peuvent s’auto-renouveler ou se différencier en cellules spécifiques aux tissus.
En raison des propriétés uniques de ces cellules, la thérapie par cellules souches peut être utilisée pour régénérer les tissus et les organes endommagés ou malades.
Les patients atteints de cancer dont les fonctions de la moelle osseuse sont altérées, tels que ceux diagnostiqués avec une leucémie, un lymphome et un myélome, sont souvent candidats à la thérapie par cellules souches.
La moelle osseuse, un tissu spongieux situé au centre des gros os, est la principale source de cellules souches hématopoïétiques ou hématopoïétiques. Sans moelle osseuse saine, un patient ne peut pas produire de cellules sanguines.
Pour commencer la thérapie par cellules souches, les patients atteints d’un cancer du sang sont d’abord exposés à de fortes doses de radiation ou de chimiothérapie pour détruire les cellules cancéreuses – une thérapie de conditionnement. Cela peut également affecter leurs cellules souches d’origine.
Ensuite, des cellules souches hématopoïétiques prélevées sur le patient – une autogreffe – ou un donneur compatible sain – une allogreffe – sont perfusées par voie intraveineuse au patient.
Au fil du temps, les cellules souches transplantées prolifèrent dans la moelle osseuse et restaurent la capacité du patient à produire des cellules sanguines saines.
View the full transcript and gain access to JoVE Core videos
Q1: What are stem cells and why are they used in therapy?
Stem cells are unspecialized cells capable of self-renewal and differentiation into tissue-specific cells. Their unique properties make them ideal for regenerative medicine, allowing them to repair and restore function to damaged or diseased tissues and organs. This potential has made stem cell therapy a promising treatment for various conditions, including blood cancers and organ damage.
Q2: How do hematopoietic stem cells help treat blood cancer patients?
Blood cancer patients with impaired bone marrow function receive conditioning therapy—high-dose radiation or chemotherapy—to destroy cancerous cells. Hematopoietic stem cells from the patient or a healthy donor are then infused intravenously. These transplanted cells proliferate in the bone marrow, restoring the patient's ability to produce healthy blood cells and recover bone marrow function.
Q3: What is the difference between autologous and allogeneic stem cell transplants?
Autologous transplants use hematopoietic stem cells harvested from the patient's own bone marrow, while allogeneic transplants use cells from a healthy matching donor. Both approaches aim to restore blood cell production after conditioning therapy. The choice depends on the patient's health condition and availability of matched donors.
Q4: Why are adult stem cells preferred over embryonic stem cells in therapy?
Adult stem cells, such as hematopoietic and mesenchymal stem cells, are more commonly used because embryonic stem cells require embryo sacrifice, raising significant ethical concerns. Although adult stem cells have limited differentiation potential compared to embryonic stem cells, they can still differentiate into various tissue types and are readily available from bone marrow and umbilical cord blood.
Q5: How does the timing of stem cell administration affect tissue repair?
Timing is crucial for repair efficiency when stem cells are administered directly to target tissues. If introduced too early after injury, the inflammatory process impairs stem cell proliferation. However, when administered during the repair phase, stem cells are more readily incorporated into tissue and can proliferate effectively to repair damage.
Q6: What factors determine the success of stem cell therapy strategies?
Stem cell therapy success depends on optimization of multiple factors: the source of stem cells, the target tissue, and the recipient's health condition. Administration route also matters—intravenous delivery works for bone marrow establishment, while direct administration at the target site is more efficient for local tissue repair in organs like the heart, kidney, liver, and muscle.
Q7: What types of tissues can mesenchymal stem cells differentiate into?
Mesenchymal stem cells, found primarily in bone marrow and umbilical cord blood, can differentiate into multiple tissue types including heart, liver, muscle, bone, and some nerve tissues. This broad differentiation potential makes them valuable for regenerative therapy applications targeting various organ systems and tissue types.